Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages
Abstract Dysbiosis of the gut microbiota has been implicated in hypertension, and drug–host–microbiome interactions have drawn considerable attention. However, the influence of angiotensin receptor blocker (ARB)‐shaped gut microbiota on the host is not fully understood. In this work, we assessed the...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-08-01
|
| Series: | iMeta |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/imt2.222 |